Representative before the EPO

Company dna probiodrug ag
no operation time available
Headquarter in Halle (Saale)
active in Legal Services

Representative before the EPO

Employment test 11 - 50 employees
Company dna maikowski and ninnemann
operating since 1989
Headquarter in Berlin and 2 offices
active in Legal Services and IP Portfolio Processing

Matthias Hoffmann has worked on the following 17 EPO patent applications which have been published in the last five years:

EP12708855

DIAGNOSTIC ANTIBODY ASSAY

IPC classification:
C07K 16/18, G01N 33/68
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
PATENT GRANTED
EP12709323

BENZ IMIDAZOLE DERIVATIVES AS INHIBITORS OF GLUTAMINYL CYCLASE

IPC classification:
A61K 31/4184, A61P 25/28, C07D 401/14, C07D 403/04, C07D 413/14, C07D 417/14
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11864435

USE OF REGULATOR OF CALCINEURIN 1 FOR MANUFACTURING MEDICAMENT FOR TREATMENT OF DISEASES ASSOCIATED WITH INCREASED NF- B ACTIVITY

IPC classification:
A61K 38/55, A61P 35/00
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12723476

RADIOLABELLED GLUTAMINYL CYCLASE INHIBITORS

IPC classification:
A61K 51/04, A61K 101/00
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
GRANT OF PATENT INTENDED
EP12857495

A METHOD OF ANTIBODY PURIFICATION

IPC classification:
C07K 1/18, C07K 1/20, C07K 1/34, C07K 16/28
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
GRANT OF PATENT INTENDED
EP12790483

INHALATION SUPPORT APPARATUS AND METHOD FOR INHALATION SUPPORT

IPC classification:
A61B 5/08, A61M 15/00, A63B 23/18
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
GRANT OF PATENT INTENDED
EP11800122

PHARMACEUTICAL COMPOSITION COMPRISING LEVOCARNITINE AND DOBESILATE

IPC classification:
A61K 31/095, A61K 31/185, A61K 31/205, A61P 9/00, A61P 9/10, A61P 13/12
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13761564

AN EXPRESSION VECTOR COMPRISING A POLYNUCLEOTIDE ENCODING A MODIFIED GLUTAMINE SYNTHETASE AND A METHOD FOR PREPARING A TARGET PROTEIN EMPLOYING THE SAME

IPC classification:
C12N 9/00, C12N 15/52, C12N 15/85
Applicant:
Ares Trading SA
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Agent:
Merck Serono S.A.
Status:
EXAMINATION IN PROGRESS
EP13187703

Method for adapting decorative prints and device for carrying out said method

IPC classification:
B41J 3/407, B41M 5/00
Applicant:
Flooring Technologies Ltd.
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14194326

Thiourea derivatives as glutaminyl cyclase inhibitors

IPC classification:
A61K 31/4164, A61K 31/4184, A61P 25/00, C07D 233/54, C07D 235/06, C07D 401/12, C07D 405/12, C07D 409/12, C07D 413/12, C07D 417/12
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
PATENT GRANTED
EP13813388

NOVEL MONOCLONAL ANTIBODY BINDING SPECIFICALLY TO DLL4 AND USE THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C12N 15/13
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
GRANT OF PATENT INTENDED
EP13194476

New mineral binder and the use thereof for the manufacturing of wood-based panels

IPC classification:
B27N 3/10, C04B 20/10, C04B 28/00, C04B 41/50, C04B 111/00, D21J 1/08, E04C 2/10
Applicant:
Kronotec AG
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
PATENT GRANTED
EP14152417

New fusion gene as therapeutic target in proliferative diseases

IPC classification:
C07K 14/435
Applicant:
Technische Universität Dresden KöR
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
EXAMINATION IN PROGRESS
EP11707182

HETEROCYCLIC INHIBITORS OF GLUTAMINYL CYCLASE (QC, EC 2.3.2.5)

IPC classification:
A61K 31/4184, A61K 31/454, A61K 31/4709, A61K 31/5377, A61P 1/04, A61P 25/18, A61P 25/28, A61P 29/00, A61P 31/04, A61P 35/00, C07D 401/04, C07D 403/04, C07D 403/10, C07D 403/14, C07D 405/10
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11745800

CRYSTAL STRUCTURE OF GLUTAMINYL CYCLASE

IPC classification:
C12N 9/10, G06F 19/16
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11708026

INHIBITORS OF PROTEIN KINASES

IPC classification:
A61K 31/44, A61K 31/4418, A61K 31/4436, A61K 31/4439, A61K 31/4545, A61K 31/496, A61P 9/00, A61P 25/00, A61P 25/28, A61P 29/00, C07D 213/75, C07D 401/12, C07D 401/14, C07D 409/12, C07D 417/12
Applicant:
AstraZeneca AB
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11776434

CRYSTAL STRUCTURE OF ISOGLUTAMINYL CYCLASE

IPC classification:
C12N 9/10, G06F 19/16
Agent:
Matthias Hoffmann, Maikowski & Ninnemann
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature